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Background: DNA methylation has been viewed as the most highly characterized epigenetic mark for genome
regulation and development. Postnatal brains appear to exhibit stimulus-induced methylation changes because of
factors such as environment, lifestyle, and diet (nutrition). The purpose of this study was to examine how extensively
the brain DNA methylome is regulated by nutrition in early life.
Results: By quantifying the total amount of 5-methylcytosine (5mC) in the thalamus and the hippocampus of
postnatal malnourished mice and normal mice, we found the two regions showed differences in global DNA
methylation status. The methylation level in the thalamus was much higher than that in the hippocampus. Then,
we used a next-generation sequencing (NGS)-based method (MSCC) to detect the whole genome methylation of
the two regions in malnourished mice and normal mice. Notably, we found that in the thalamus, 500 discriminable
variations existed and that approximately 60% were related to neuronal development or psychiatric diseases.
Pathway analyses of the corresponding genes highlighted changes for 9 genes related to long-term potentiation
(5.3-fold enrichment, P = 0.033).
Conclusions: Our findings may help to indicate the genome-wide DNA methylation status of different brain regions
and the effects of malnutrition on brain DNA methylation. The results also indicate that postnatal malnutrition may
increase the risk of psychiatric disorders.
Keywords: Malnutrition, Thalamus, Hippocampus, Mouse model, Global DNA methylation status, Whole genome
methylation sequencing, Long-term potentiation, Psychiatric disordersBackground
Nutrition represents one of the major important variables
that play crucial roles in the maturation and functional de-
velopment of the central nervous system (CNS) [1]. Mal-
nutrition exerts its effects during the brain growth spurt
period, and it results in a variety of brain dysfunctions [2].* Correspondence: helin@bio-x.cn; superliuyun@gmail.com
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reproduction in any medium, provided the orGrowth deficits due to malnutrition in childhood increase
the incidence of infectious diseases and lead to alterations
in CNS function, which have been shown to delay psycho-
motor development [3]. Thus, understanding the patho-
logical effects of malnutrition will provide critical insights
into the neurodevelopmental process.
DNA methylation is among the best studied epigenetic
modifications and is essential to mammalian development
[4]. Specifically, the methylation of cytosine at CpG dinu-
cleotides is an important regulatory modification of the
genome [5]. Many epigenetic studies on DNA methylationtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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is highly correlated with abnormal neurodevelopment [6].
Studies of epigenetic modifications benefit substantially
from improved next-generation sequencing methods, and
recent technologies make it possible for accurate and large-
scale CpG methylation profiling [7]. Methyl-sensitive cut
counting (MSCC) is a NGS method used to profile the
whole DNA methylome. The MSCC genome-scale analysis
is based on the concept that locations of CCGGs largely re-
flect the distributions of all CpGs in the mouse genome [8].
In our study, we utilized a mouse model of male mice
to avoid sex differences, as sexual dimorphism and sex-
ual differentiation have been thought to underlie the
sexual development of the brain and other organs, which
could impact lifelong functions [9]. First, we detected
the global DNA methylation status in the thalamus and
the hippocampus of postnatal malnourished mice and
normal mice. Because the two regions showed differ-
ences in global DNA methylation status, we employed
MSCC to investigate DNA methylation to determine
how extensively the two brain DNA methylomes were
regulated by nutrition in early life.
Methods
Mouse husbandry
All animal care and use procedures were in accordance
with the guidelines of the Institutional Animal Care and
Use Committee for Nutritional Sciences, Shanghai Insti-
tutes for Biological Sciences, Chinese Academy of Sci-
ences. The parental mice in this study were purchased
from Shanghai Laboratory Animal Co. Ltd. (SLAC,
Shanghai, China) and housed under controlled condi-
tions of 12 h light/12 h dark cycle at 23 ± 2°C and 35 ±
5% humidity. The parental mice had been raised for at
least two generations on a control diet to attempt to
minimize any trans-generational effects. The male off-
spring mice were weaned from the mothers at 20 days of
age and were divided randomly into two groups (n = 7 in
control group, n = 5 in famine group): the control group
was given a standard diet (D12450B), and the famine
group was fed with half of a low-protein diet (D06022301)
[10]. After 6 weeks of artificial feeding, offspring mice
were euthanized (the weights of the offspring mice were
measured every week from weaning); the entire tha-
lamus and hippocampus were dissected out and imme-
diately stored at −80°C.
DNA preparation
Genomic DNA was isolated from ≥25 mg samples (thal-
amus and hippocampus of malnourished mice and normal
mice) using the QIAamp DNA Mini Kit following the
standard protocol (QIAGEN, Hilden, Germany). To ensure
the sample quality, a Thermo NanoDrop 2000 (Thermo,
Wilmington, USA) was used to detect 260/280 nm UVabsorbance ratios, and concentrations were determined
with a Qubit 2.0 fluorometer (Life Technologies, Carlsbad,
CA). DNA length was determined by an Agilent 2100
Bioanalyzer (Agilent, Santa Clara, CA) to ensure the integ-
rity. We constructed two MSCC libraries for each of our
two brain tissues that contained pooled DNA from the
control group and the famine group. Pooled DNA was
used to increase the sample concentration and diminish
micro-dissection variations.
Global DNA methylation status detection and calculation
The MethylFlash™ Methylated DNA Quantification Kit
(Fluorometric) was used to detect the total amount of
5mC in the thalamus and hippocampus according to the
manufacturer’s instructions (Epigentek, Farmingdale, NY).
Relative fluorescence units (RFU) at 530EX/590EMnm were
measured using a SpectraMax M5 (Molecular Devices,
CA, USA) to calculate the global methylation status.
MSCC library construction
To detect cytosine methylation, MSCC utilized the re-
striction enzymes HpaII and MspI, which preferentially
cut DNA based on its methylation status. Although both
enzymes recognized the same restriction site CCGG,
HpaII was a methylation-sensitive enzyme, while MspI
was insensitive to methylation sites. Adaptors A and B
were also created for MSCC and were synthesized by
Sangon Biotech (Shanghai, China). Adaptor A contained
a 5′ MmeI recognition site and a 5′ CG overhang, while
adaptor B had a 3′ NN overhang. Both adapters also
contained end sequences required for Illumina library
construction. Then, we constructed a HpaII library and
an Inverse library for our study. To correct the error
during the experiment of the HpaII library and the In-
verse library, we combined standard DNA in the two li-
braries that contained the same known methylated or no
methylated sequences. Further details are provided in
the Additional file 1: Supplementary Method.
Library sequencing and mapping
Before sequencing, we used a Perl script to extract 20 bp
upstream and 20 bp downstream of every CCGG site
from the whole mouse genome (mm9). Based on the
UCSC Refseq database, we added annotation to these
short sequences and established a CCGG sequence data-
base. The two libraries were sequenced on the Hiseq2000
depth sequencing system (Illumina, San Diego, California).
After sequencing, the HpaII library and the Inverse library
data from the Hiseq2000 depth sequencing system (bcl
document) were transformed into a fastq file using
CASAVA software. The fastq file data were mapped to the
CCGG sequence database that we constructed using MOM
software. We then analyzed the number of reads in the
same CCGG position to calculate the degree of methylation
Figure 1 The global DNA methylation levels in the thalamus
and hippocampus of postnatal malnourished mice and normal
mice. Data are the mean ± s.e.m. *P = 0.046 (control group and
famine group in the hippocampus, Student’s t-test). **P = 6.413e-05
(control group in the thalamus and hippocampus, Student’s
t-test); 4.394e-04 (famine group in the thalamus and
hippocampus, Student’s t-test).
Table 1 Mouse weights from the beginning of artificial feeding
Group Weight (g)/week
0 1 2 3 4 5 6
Control 8.69 ± 0.32 19.06 ± 0.85 21.57 ± 1.21 23.29 ± 1.08 24.53 ± 1.57 25.51 ± 2.02 26.04 ± 1.87
Famine* 8.69 ± 0.27 8.82 ± 0.77 10.28 ± 0.44 12.46 ± 0.50 13.32 ± 0.68 13.02 ± 0.94 11.45 ± 0.78
*P < 0.05, compared with the control group.
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normalize the counts before estimating the methylation
level, according to the method in Guo et al. [8].
Statistical analysis
Student’s t-tests were used to determine the differences in
mouse weights and thalamus and hippocampus methyla-
tion levels between the control group and the famine
group. For the MSCC data, we constructed a 200-bp
non-overlapping windows profiling of the whole genome.
Windows that involved more than 3 CpG sites sequenced
were used for the subsequent analysis. For each of the
200-bp windows, we conducted Fisher exact tests to find
different methylated regions (DMRs) with statistical
significance (P < 0.05) and different levels of methylation
changes (ΔMSCC, either increase or decrease) >25%. A P
value < 0.05 was considered significant in these analyses.
Pathway classification and enrichment analysis
Pathway analyses were performed using the Database
for Annotation, Visualization and Integrated Discovery
(DAVID, http://david.abcc.ncifcrf.gov/) [11]. Pathway
classification within DAVID used the Kyoto Encyclopedia
of Genes and Genomes database (KEGG, http://www.gen-
ome.jp/kegg/pathway.html) and PANTHER (http://www.
pantherdb.org/pathway/). Enrichment statistics were
adjusted by Benjamini correction.
Results
Weight
The weights of the offspring male mice are shown in
Table 1. Data are presented as the mean ± standard devi-
ation (SD). As determined using Student’s t-test, the
famine group weighed less and the weights were signifi-
cantly different from the control group (p < 0.05). During
feeding, the famine group displayed the phenomena of
mania and hyperactivity.
Total 5mc amount in the thalamus and hippocampus
The global DNA methylation status in the thalamus and
the hippocampus of postnatal malnourished mice and
normal mice is shown in Figure 1. The global DNA
methylation status in the thalamus was significantly
higher than that of the hippocampus. In both the thal-
amus and the hippocampus, the control group had a
higher total 5mc amount than the famine group.DNA methylome in the thalamus and hippocampus
The reads obtained from our libraries after MSCC whole
genome methylation sequencing are shown in Table 2.
After excluding MSCC sites with low sequencing depth,
we obtained the DNA methylation profile of the thal-
amus (Additional file 2: Table S1) and the hippocam-
pus (Additional file 3: Table S2). The overall
methylation levels of all CCGG sites in the two tissues
are shown in Figure 2. The CCGG methylation level of
the hippocampus was also lower than that of the thalamus
as the global DNA methylation status. The methylation
differences between the famine and control groups or the
thalamus and hippocampus were statistically significant
(P < 0.001).
In addition, we also showed the methylation level in
internal, shore and external CGIs of the thalamus and
the hippocampus (Additional file 1: Figure S1a and S1b).
In the two groups of both tissues, the level of methyla-
tion in the internal of the CpG islands was lower than
that of the external of the CpG islands. Furthermore, the
famine group had a lower methylation level than the
control group at the external of the CpG islands,
whereas it was hypermethylated in the internal of the
CpG islands in both brain regions. The whole genome
methylation pattern showed that the methylation level
near the transcription initiation site (TSS) was lower
than any other position (Additional file 1: Figure S2).
Figure 2 The overall methylation levels of all CCGG sites in the
thalamus and hippocampus (control group in gray and famine
group in white). The total methylation level at CCGG sites of the
hippocampus was lower than that of the thalamus. ***P < 0.001
(control group and famine group in the thalamus and
hippocampus, control group in the thalamus and hippocampus,
famine group in the thalamus and hippocampus, Student’s t-test).
Table 2 MSCC Illumina sequencing statistics of the thalamus and hippocampus




Number of CCGG sites
seen at least once
Average number of
reads per CCGG site
Thalamus Control-HpaII 39239224 31413443 (80.0) 1034841 30.4
Control-Inverse 35769649 20466887 (57.2) 1118555 18.3
Famine-HpaII 57387236 46262199 (80.6) 1076064 43
Famine-Inverse 46472846 27799576 (59.8) 1175605 23.6
Hippocampus Control-HpaII 29639848 24301025 (81.2) 1060634 22.9
Control-Inverse 26585724 15892801 (59.8) 1136208 14.0
Famine-HpaII 37551216 30429853 (81.0) 1125683 27.0
Famine-Inverse 42435514 25510407 (60.1) 1191446 21.4
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data from the NCBI GEO database (GDS1490) with our
MSCC thalamus data for the control group. First, we di-
vided the database expression genes into three parts:
high-expression genes, moderate-expression genes, and
low-expression genes. Then, the MSCC data were in-
tegrated to the three parts of the expression genes. The
relationship between the methylation level and gene ex-
pression is shown in Additional file 1: Figure S3a and
S3b. The methylation level of the low-expression genes
was higher at TSS but lower at the gene body than that
of the high-expression genes.Table 3 Twenty crucial genes related to psychiatric
diseases among 500 selected genes of the thalamus
Gene name Related psychiatric diseases
Slc18a2 Schizophrenia [12], Alzheimer’s disease [13],
Parkinson’s disease [14]
Pi4k2b Bipolar disorder [15]
Prkacb Alzheimer’s disease [16]
Gabra1 Schizophrenia [17]
Bdnf Alzheimer’s disease [18], Major depression disorder [19]
Katnb1 Bipolar disorder [20]
Psen1 Alzheimer’s disease [21]
Pde4a Schizophrenia [22], Bipolar disorder [23]
Lrfn5 Autism [24]
Ppp3ca Alzheimer’s disease [25,26]
Shank3 Autism spectrum disorder [27,28], Bipolar disorder [29]
Clu Alzheimer’s disease [30,31]
Notch4 Bipolar disorder [32], Schizophrenia [33]
Sult4a1 Schizophrenia [34]
Rnf11 Parkinson’s disease [35]
Pclo Major depression disorder [36], Bipolar disorder [37]
Tyro3 Alzheimer’s disease [38]
Calm2 Major depression disorder [39]
Cacna1c Schizophrenia [40-42], Bipolar disorder [43-45]
Plcb1 Autism spectrum disorder [46], Schizophrenia [47]
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(Additional file 4: Table S3) but none in the hippocam-
pus, according to the results of the DMR analysis. Further-
more, all 500 selected genes obtained from the thalamus
analysis of the famine group showed hypermethylation,
and approximately 60% of the genes were associated with
neuronal development and psychiatric diseases. The 20
crucial genes identified as being implicated in psychiatric
diseases are shown in Table 3.
Properties of the hypermethylated genes
To gain mechanistic insights into the CpG modifications,
we constructed our 500 gene set corresponding to bio-
logical pathways and networks underlying complex diseases
using the online tool DAVID. In total, 20 pathways were
matched with our gene sets, as shown in Table 4. The most
highly enriched pathway, which remained significant after
the adjustment for multiple hypothesis testing using the
conservative Benjamini correction, was long-term potenti-
ation (LTP, 5.3-fold enrichment, P = 0.033) with 9 relative
genes from our study: Ppp1r1a, Ppp3r1, Raf1, Camk2b,
Ppp3ca, Prkacb, Cacna1c, Plcb1, and Calm2 (Figure 3).
Discussion
In contrast to previous studies that focused mainly on the in-
fluence of maternal malnutrition on fetal neurodevelopmentTable 4 Twenty KEGG and PANTHER pathways applied to the
Category Pathway
KEGG_PATHWAY Long-term potentiation
KEGG_PATHWAY MAPK signaling pathway
PANTHER_PATHWAY Alzheimer disease-amyloid secretase pathway
KEGG_PATHWAY Long-term depression
KEGG_PATHWAY GnRH signaling pathway
KEGG_PATHWAY Calcium signaling pathway
KEGG_PATHWAY Vascular smooth muscle contraction
KEGG_PATHWAY Wnt signaling pathway
KEGG_PATHWAY Melanogenesis
PANTHER_PATHWAY TGF-beta signaling pathway
KEGG_PATHWAY Ubiquitin mediated proteolysis
PANTHER_PATHWAY Endogenous_cannabinoid_signaling
PANTHER_PATHWAY PDGF signaling pathway
KEGG_PATHWAY Glycerophospholipid metabolism
PANTHER_PATHWAY Endothelin signaling pathway
PANTHER_PATHWAY Notch signaling pathway
PANTHER_PATHWAY Metabotropic glutamate receptor group II pathw
KEGG_PATHWAY Neurotrophin signaling pathway
PANTHER_PATHWAY Ionotropic glutamate receptor pathway
KEGG_PATHWAY N-Glycan biosynthesis[1-3, 10], our study provides a striking view of how the
epigenetic DNA methylation landscape of the thalamus
and the hippocampus in postnatal individuals is modified in
response to malnourishment. We describe a genome-wide,
quantitative characterization of malnourishment-induced
CpG methylation changes in postnatal mice. These data
may serve as a useful resource for the neuroscience
community and brain science studies.
Our study demonstrated several key aspects of
malnourishment-induced epigenetic DNA modifications
in mice. First, the global DNA methylation status in the
thalamus and the hippocampus of postnatal malnourished
mice and normal mice had significant differences. This told
us that the mechanism of the malnourishment-induced epi-
genetic DNA modifications in the thalamus was different
from the hippocampus. Second, our analysis revealed
specific characteristics of the genomic DNA methyla-
tion distribution in the thalamus and the hippocampus
of malnourished mice and normal mice. Third, our
MSCC results provided direct profiling regarding the
malnourishment-induced DNA methylation changes in
both the thalamus and the hippocampus. Fourth, our
study provided a large number of genes that were
subjected to modulation by malnourishment at the level
of DNA modification. The majority of these genes were
associated with neuronal occurrence and development.500 hypermethylated genes in the thalamus
Count Fold Benjamini
Enrichment P value P value
9 5.270 2.58 × 10-4 0.033
16 2.475 0.002 0.108
9 3.872 0.002 0.147
7 3.985 0.008 0.283
8 3.380 0.009 0.250
11 2.360 0.017 0.360
8 2.732 0.026 0.433
9 2.476 0.028 0.405
7 2.869 0.034 0.428
10 2.080 0.046 0.876
8 2.411 0.046 0.496
4 4.832 0.047 0.757
11 1.930 0.052 0.698
5 3.059 0.078 0.654
7 2.290 0.080 0.772
5 2.963 0.084 0.727
ay 5 2.908 0.088 0.691
7 2.207 0.095 0.692
5 2.804 0.098 0.682
4 3.564 0.100 0.679
Figure 3 The 9 relative genes marked with red stars: Ppp1r1a(I-1), Ppp3r1(CaN), Raf1(Raf), Camk2b(CaMKII), Ppp3ca(CaN), Prkacb(PKA),
Cacna1c(VDCC), Plcb1(PLC), and Calm2(CaM) in the most significant identified pathway, i.e., long-term potentiation.
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(CGIs), and most CGIs remain unmethylated [48].
Moreover, approximately 60% of mammalian genes have
CGI promoters, and methylated CGIs play an important
role in gene silencing during processing [49]. The best-
known producer of epigenesis, DNA methylation, plays
an important role in regulating gene expression to pre-
serve local activity states [50]. Epigenesis is defined as
heritable changes in gene expression that are not accom-
panied by changes in DNA sequence [51]. Thus, to re-
flect the DNA methylation landscape and distribution,
we measured the methylation level in different regions
of the genome. To gain more insight into whether the
changes caused by methylation were present on the gene
expression level, we performed comparisons between our
MSCC data and the gene expression data (GDS1490). All
our results were in accordance with the theoretical basic
characteristics of DNA methylation modification in mam-
mals, which confirmed the accuracy of our experiment.
It should be noted that when we used our criteria
(ΔMSCC > 25%) to screen out differential genes in the
normal and famine groups, no genes were selected in
the hippocampus, while 500 distinct genes were revealed
in the thalamus. This may due to the selected CCGG
methylated level in the hippocampus, which was much
lower than that in the thalamus. Thus, a methylation
level of >25% was difficult to achieve in the hippocam-
pus. In this regard, further study of the hippocampus,
which has vital roles in brain development, cognition,
learning, and memory [52], would provide valuable
information.
In the thalamus, the most significant identified relative
pathway was long-term potentiation. It is a major form
of long-lasting synaptic plasticity in the mammalianbrain, which occurs by increasing synaptic strength, and
is involved in information storage, and therefore, in
learning and memory [53]. Ppp1r1a, Ppp3r1, Raf1,
Camk2b, Ppp3ca, Prkacb, Cacna1c, Plcb1, and Calm2
were the filtered genes in this pathway from our study.
These genes are critically involved in neuronal formation
and development. Among the 9 genes, Camk2b plays
important roles in brain synaptic plasticity [54]. Ppp3ca
is a tumor suppressor gene that functions in Alzheimer’s
disease [25,26]. Prkacb is a protein kinase and is related
to Alzheimer’s disease [16]. Plcb1 is of critical import-
ance in codifying neurotransmitter receptors and is asso-
ciated with schizophrenia [46,47]. It is particularly
noteworthy that the calcium channel, voltage-dependent,
L-type, alpha 1C subunit (Cacna1c) gene contributes to
many psychiatric disorders [55,56], specifically schizo-
phrenia [40-42] and bipolar disorder [43-45].
Our study considered the global DNA methylation sta-
tus of the thalamus and the hippocampus and provides a
DNA methylation landscape of these two brain regions
after they were modified by malnutrition. It also impli-
cates DNA modification as an effective epigenetic regu-
lator in postnatal brain maturation. Our data also
indicate that malnutrition in postnatal individuals may
increase the risk of developing psychiatric disorders such
as Alzheimer’s disease, schizophrenia and bipolar dis-
order. Nonetheless, we believe that much more research
on the functional verification of the related genes is ne-
cessary to obtain a better understanding of the patho-
genesis of malnutrition.
Conclusions
In this study, the thalamus and the hippocampus had
different global DNA methylation statuses in postnatal
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http://www.biomedcentral.com/1471-2202/15/31malnourished mice and normal mice. Discriminable var-
iations related to neuronal development and psychiatric
disorders were also observed in the thalamus. Pathway
analyses of the corresponding genes highlighted changes
for 9 genes related to long-term potentiation (5.3-fold
enrichment, P = 0.033). Our findings may help to differ-
entiate the genome-wide DNA methylation status of
different brain regions, and the results also indicate that
postnatal malnutrition may increase the risk of psy-
chiatric disorders.
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Additional file 1: Supplementary materials.
Additional file 2: Table S1. MSCC results of the thalamus for all MSCC
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Additional file 3: Table S2. MSCC results of the hippocampus for all
MSCC 30+ sites.
Additional file 4: Table S3. Selected 500 distinctive genes in the
thalamus.
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